Up to 54 % of patients studied did not complete their full course of ferrous sulfate as prescribed . 1 *
Move to Maltofer ®
Maltofer ® restores iron levels with significantly less constipation and better treatment compliance than ferrous sulfate . 1 – 3
Fewer pregnant women experience constipation with Maltofer ® 1 *
Ferrous sulfate 23 % of patients
Maltofer ®
2 % of patients
Maltofer ® contains iron as iron polymaltose . For more information visit maltofer . com . au * In a study comparing iron polymaltose with ferrous sulfate in iron deficient pregnant patients . n = 80 . References : 1 . Ortiz R et al . J Matern Fetal Neonatal Med 2011 ; 24:1 – 6 . 2 . Toblli JE & Brignoli R . Arzneimittelforschung 2007 ; 57:431 – 38 . 3 . Jacobs P et al . Hematology 2000 ; 5:77 – 83 . Healthcare professionals should review the full product information before recommending , which is available from Vifor Pharma on request .
Maltofer is for the treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated , or otherwise inappropriate . For the prevention of iron deficiency in adults and adolescents determined by a medical practitioner to be at high-risk , where the use of ferrous iron supplements is not tolerated , or otherwise inappropriate . If you have iron deficiency , your doctor will advise you whether an oral iron treatment is required .
Maltofer ® is a registered trademark of Vifor Pharma used under licence by Aspen Pharmacare Australia Pty Ltd . For medical and product enquiries , contact Vifor Pharma Medical Information on 1800 202 674 . For sales and distribution enquiries , contact Aspen Pharmacare customer service on 1300 659 646 . AU-MAL-1900004 . ASPHCH1150 / AD . Date of preparation August 2019 .